1. Home
  2. A vs MKL Comparison

A vs MKL Comparison

Compare A & MKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • A
  • MKL
  • Stock Information
  • Founded
  • A 1999
  • MKL 1930
  • Country
  • A United States
  • MKL United States
  • Employees
  • A N/A
  • MKL N/A
  • Industry
  • A Biotechnology: Laboratory Analytical Instruments
  • MKL Property-Casualty Insurers
  • Sector
  • A Industrials
  • MKL Finance
  • Exchange
  • A Nasdaq
  • MKL Nasdaq
  • Market Cap
  • A 29.3B
  • MKL 24.4B
  • IPO Year
  • A 1999
  • MKL 1986
  • Fundamental
  • Price
  • A $112.93
  • MKL $1,976.89
  • Analyst Decision
  • A Buy
  • MKL Sell
  • Analyst Count
  • A 11
  • MKL 4
  • Target Price
  • A $139.45
  • MKL $1,727.75
  • AVG Volume (30 Days)
  • A 1.8M
  • MKL 44.9K
  • Earning Date
  • A 08-27-2025
  • MKL 07-30-2025
  • Dividend Yield
  • A 0.88%
  • MKL N/A
  • EPS Growth
  • A N/A
  • MKL N/A
  • EPS
  • A 4.06
  • MKL 135.94
  • Revenue
  • A $6,628,000,000.00
  • MKL $15,553,213,000.00
  • Revenue This Year
  • A $6.34
  • MKL N/A
  • Revenue Next Year
  • A $5.53
  • MKL $5.54
  • P/E Ratio
  • A $27.72
  • MKL $14.60
  • Revenue Growth
  • A 0.56
  • MKL N/A
  • 52 Week Low
  • A $96.43
  • MKL $1,491.03
  • 52 Week High
  • A $153.84
  • MKL $2,063.68
  • Technical
  • Relative Strength Index (RSI)
  • A 39.51
  • MKL 51.88
  • Support Level
  • A $118.90
  • MKL $1,966.01
  • Resistance Level
  • A $126.44
  • MKL $2,010.67
  • Average True Range (ATR)
  • A 3.30
  • MKL 29.90
  • MACD
  • A -0.58
  • MKL -3.25
  • Stochastic Oscillator
  • A 6.89
  • MKL 42.06

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About MKL Markel Group Inc.

Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.

Share on Social Networks: